Karyopharm - oncology

Quote

anonymous said:
anyone wonder why they are not attending leerink conf ??? Ok I'll answer. When the company that you lead is barely listed on the market at less than 50 million mc.........you are a joke and not taken seriously. Can you imagine being in charge of such wealth destruction. Simply cannot make it up. Just sit and watch the accident happen in real time and do NOTHING to stop or try to stop it.
Click to expand...
Over a million dollars a year in salary to polish a turd not too bad...wonder what special certification is required
 








The board just have hime 20k shares and 40 k options. What exactly has he done to earn these awards ? He has t accomplish one thing while ceo in my opinion. Rev is non existent, failed trials (MDS) and major fumbles of other trials especially as the need for exactitude and urgency have arose the past 12 months. How can the board award him these ?? They should all go to jail.
 








anonymous said:
The board just have hime 20k shares and 40 k options. What exactly has he done to earn these awards ? He has t accomplish one thing while ceo in my opinion. Rev is non existent, failed trials (MDS) and major fumbles of other trials especially as the need for exactitude and urgency have arose the past 12 months. How can the board award him these ?? They should all go to jail.
Click to expand...
These recent stock awards are almost beside the point. The fact that he hasn’t been fired long before this is unforgivable shows that the board is completely ineffectual and nothing but a bunch of eunuchs. On every key performance metric that a chief executive would normally be assessed by the BOD - sales/market share growth, shareholder value creation. clinical trial progress and meeting timelines, strategic alliance development and management - he’s failed pathetically. There’s no excuse. The board needs to be replaced by activist shareholders ASAP so a management shakeup can occur.
 








Too late…..this
anonymous said:
These recent stock awards are almost beside the point. The fact that he hasn’t been fired long before this is unforgivable shows that the board is completely ineffectual and nothing but a bunch of eunuchs. On every key performance metric that a chief executive would normally be assessed by the BOD - sales/market share growth, shareholder value creation. clinical trial progress and meeting timelines, strategic alliance development and management - he’s failed pathetically. There’s no excuse. The board needs to be replaced by activist shareholders ASAP so a management shakeup can occur.
Click to expand...
thing is over……..final knockout blow will be when mf results underwhelm. CEO’s only skill is to dangle different carrots from time to time. Maybe for his next job he can stand behind a box in nyc and play 3 card Monty. He’d be very good at it.
 








Why any of us do any work here anymore is just insane. I’ve tried to stay positive. Just do my job and hope MF comes through. After the reverse split I was hopeful that this would see us through. That hope is gone. If you do the math and undid the split the share piece would be down in the 40 cent range! Wall Street has spoken. They do not believe our CEO at all. Other companies have spoken as many of them, on the cheap, could swoop in and pick up an asset. No one has so they don’t see it either. I’m sick of the arrogance and the false bravado. All credibility is gone.

We were warned about this Exec. Team…the warnings were actually undersold. You have lost many of us…now you lost me. I’m done.
 








anonymous said:
Why any of us do any work here anymore is just insane. I’ve tried to stay positive. Just do my job and hope MF comes through. After the reverse split I was hopeful that this would see us through. That hope is gone. If you do the math and undid the split the share piece would be down in the 40 cent range! Wall Street has spoken. They do not believe our CEO at all. Other companies have spoken as many of them, on the cheap, could swoop in and pick up an asset. No one has so they don’t see it either. I’m sick of the arrogance and the false bravado. All credibility is gone.

We were warned about this Exec. Team…the warnings were actually undersold. You have lost many of us…now you lost me. I’m done.
Click to expand...
But he just earned 20k shares and 40k stock options. Let that sink in a little. What did u get in return? A free pretzel bagel this morning??
 
















anonymous said:
The board just have hime 20k shares and 40 k options. What exactly has he done to earn these awards ? He has t accomplish one thing while ceo in my opinion. Rev is non existent, failed trials (MDS) and major fumbles of other trials especially as the need for exactitude and urgency have arose the past 12 months. How can the board award him these ?? They should all go to jail.
Click to expand...
If ever there was a justification for a class action suit, this is it
 








The ceo of our company botched the Endo trial so bad that perhaps he should go back to ninth grade chem class. How many swings and a miss do you now get in corporate America. Time for him to hit the showers and a more capable ceo take the reins.
 








































anonymous said:
I’ve written the SEC everyday for past year about looking into this company. Finally got an acknowledgement today. Hopefully some action soon.
Click to expand...
Just write the cover letter for them:

The Securities and Exchange Commission today charged XXXXXXX XXXXXXX, the former CEO of XXXXXXXX Inc, with fraud and insider training in connection with providing misleading information to shareholders about the progress of a clinical research treatment for XXXXXXXX.

According to the SEC's complaint, XXXXXXX XXXXXXX repeatedly issued press releases exaggerating XXXXXXXXXXX’s progress with regard to XXXXXXX. The complaint alleges that in an XXX 202X press release, falsely announced that the company had submitted a completed Application to the U.S. Food and Drug Administration-a key milestone that caused the company's stock price to increase. As set forth in the complaint, the FDA submission was woefully inadequate, and the FDA alerted the company of those deficiencies within days, however, XXXXXXX XXXXXXX did not alert shareholders to this information. In the meantime, XXXXXXX allegedly sold approximately $X.X million worth of XXXXXXXXXX stock based on the false information, netting profits of more than $X.X million.
 
















Top Bottom
Back
Quote